https://www.taxtmi.com/acts?id=17067 Form B requires the appointed cost accountant to certify whether full information was obtained and whether proper cost records for the pharmaceutical company have been maintained to show true cost of production, cost of sales and margins; to report on unit wise and product/activity wise cost statements, conformity with Companies Act requirements and applicable cost accounting principles and standards, and to note material deficiencies or suggestions. The Annexure prescribes Proformas A-I and schedules for detailed quantitative data, cost of production and sales, allocation and apportionment of expenses, reconciliation with financial accounts, and process specific disclosures for fermentation and chemical processes. en-us Thu, 06 Dec 2012 18:43:49 +0530 Thu, 06 Dec 2012 18:43:49 +0530 TaxTMI RSS Generator https://www.taxtmi.com/acts?id=17067 Form B requires the appointed cost accountant to certify whether full information was obtained and whether proper cost records for the pharmaceutical company have been maintained to show true cost of production, cost of sales and margins; to report on unit wise and product/activity wise cost statements, conformity with Companies Act requirements and applicable cost accounting principles and standards, and to note material deficiencies or suggestions. The Annexure prescribes Proformas A-I and schedules for detailed quantitative data, cost of production and sales, allocation and apportionment of expenses, reconciliation with financial accounts, and process specific disclosures for fermentation and chemical processes. Act-Rules Companies Law Thu, 06 Dec 2012 18:43:49 +0530 https://www.taxtmi.com/acts?id=17067